A New Beat: Improving Cardiovascular Care in Women and Underserved Populations

Join us for an afternoon CME program covering the appropriate use of innovative medical and device-specific therapies for cardiovascular conditions in women and minorities.

Thursday, May 30, 2019
2:00 pm – 5:30 pm

Pryor Cashman
Conference Room F/G
7 Times Square
New York, NY 10036

Register here


Nisha Jhalani, MD
Cardiovascular Research Foundation
Columbia University Irving Medical Center

Cheryl Pegus, MD
Association of Black Cardiologists
CMO, Cambia Health Solutions



Kelly M. Axsom, MD
NewYork-Presbyterian/Columbia University Irving Medical Center

Erika Berman Rosenzweig, MD
NewYork-Presbyterian/Columbia University Irving Medical Center

Rachel Bond, MD
Lenox Hill Hospital/Northwell Health

Keith C. Ferdinand, MD
Tulane University Heart and Vascular Institute

Philip Green, MD
NewYork-Presbyterian/Columbia University Irving Medical Center

Mayra Guerrero, MD
Mayo Clinic

Nadira Hamid, MD
NewYork-Presbyterian/Columbia University Irving Medical Center

Jennifer H. Haythe, MD
NewYork-Presbyterian/Columbia University Irving Medical Center

Ajay J. Kirtane, MD, SM
NewYork-Presbyterian/Columbia University Irving Medical Center

Martin B. Leon, MD
NewYork-Presbyterian/Columbia University Irving Medical Center

Roxana Mehran, MD
Mount Sinai School of Medicine

Vivian G. Ng, MD
NewYork-Presbyterian/Columbia University Irving Medical Center

Sahil A. Parikh, MD
NewYork-Presbyterian/Columbia University Irving Medical Center

Jessica M. Peña, MD
Weill Cornell Medicine

Stacey E. Rosen, MD
Northwell Health

Robert J. Sommer, MD
NewYork-Presbyterian/Columbia University Irving Medical Center


2:00 – 2:10 pm
Welcome and A Call to Arms
Cheryl Pegus, MD and Nisha Jhalani, MD

2:11 – 2:25 pm
Time to Stop Passing the Buck: What Every Cardiologist in 2019 Needs to Know About Cardiometabolic Risk Reduction and the Treatment of Diabetes Mellitus
Keith C. Ferdinand, MD

2:26 pm – 2:45 pm
Panel Discussion
Keith C. Ferdinand, MD, Sahil A. Parikh, MD,
Jessica M. Peña, MD, Stacey E. Rosen, MD

2:46 – 3:00 pm
The Approach to the High-Risk of Bleeding Patient
Roxana Mehran, MD

3:01 – 3:20 pm
Panel Discussion
Rachel Bond, MD, Roxana Mehran, MD,
Vivian G. Ng, MD, Robert J. Sommer, MD

3:21 – 3:35 pm
Who Ya Gonna Call? Clot Busters! – The Spectrum of Therapies Available in Caring for Complex Venous Thromboembolic Disease
Erika Berman Rosenzweig, MD

3:36 pm – 3:55 pm
Panel Discussion
Erika Berman Rosenzweig, MD, Philip Green, MD,
Jennifer H. Haythe, MD, Ajay J. Kirtane, MD, SM

3:56 – 4:10 pm
Beyond Aortic Stenosis: Non-Surgical Mitral and Tricuspid Valve Therapies
Mayra Guerrero, MD

4:11 pm – 4:30 pm
Panel Discussion
Kelly M. Axsom, MD, Mayra Guerrero, MD,
Nadira Hamid, MD, Martin B. Leon, MD

4:30 pm – 5:30 pm
Networking Reception
Network with program faculty and colleagues


The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians and by the American Board of Internal Medicine to provide Maintenance of Certification (MOC) points. The Cardiovascular Research Foundation designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Documentation of awarded credit is provided for registered attendees who complete the activity evaluation on the CRF events app or online at Certificates of attendance are available to all registered attendees. Maintenance of Certification (MOC) program: Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.


By the end of this program, participants should be able to:

  • Describe gender disparities in healthcare, particularly among minorities, role of women healthcare leaders in improving quality of care for female patients.
  • Define cardiometabolic risk reduction and the newest diabetes treatment options in patients living with heart disease.
  • Identify approaches for patient selection in LAAC in women with AF and available options for oral anticoagulation.
  • Explain the range of therapeutic options in acute and chronic VTE ranging from systemic anticoagulation, catheter-directed thrombolysis, balloon pulmonary angioplasty, and pulmonary thromboendarterectomy.
  • Identify novel interventional valvular therapies available to patients with severe mitral or tricuspid regurgitation who are too high risk for surgery.


This educational activity is designed for clinical cardiologists, interventional cardiologists, primary care providers, residents and fellows, midlevel practitioners, nurses, technicians, administrators, and operations managers.


Evaluation by questionnaire will address content, presentation effectiveness, possible bias, and future educational needs.


It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and therefore, does not compromise the scientific integrity of the educational activity. Discussion of off-label product usage is made at the sole discretion of the faculty. Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation or the course directors of this activity. Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty in noncompliance with this policy are not permitted to participate in this activity.


This program is sponsored by the Association of Black Cardiologists & the Cardiovascular Research Foundation and is supported through educational grants from AstraZeneca, Bristol-Myers Squibb, and Medtronic. The Cardiovascular Research Foundation ensures that its programs are educational and meet the needs of the target audience. This program was developed without influence from commercial supporters.


Back to Calendar

Event Details